Biopharma PEG to Showcase Innovative PEG Derivatives at BIO 2024 in San Diego

May 19, 2024

Biopharma PEG, a renowned leader in the development and supply of high-quality polyethylene glycol (PEG) derivatives, is pleased to announce its participation in the BIO International Convention 2024. The event will take place from June 3-6, 2024, at the San Diego Convention Center, and attendees can visit Biopharma PEG atBooth 5102.

As a pivotal player in the bio-pharmaceutical industry, Biopharma PEG specializes in producing monodispersed, polydispersed, and multi-arm PEGs, which are essential for a variety of applications including Antibody-Drug Conjugates (ADCs), Proteolysis Targeting Chimeras (PROTACs), Lipid Nanoparticle (LNP) delivery systems, hydrogels, and 3D printing, etc. These cutting-edge PEG derivatives are critical in enhancing the efficacy, safety, and delivery of pharmaceutical and biotechnological products.

"We are thrilled to be part of BIO 2024, an event that brings together the brightest minds and most innovative companies in the biotech industry," said Dr. Deng, CEO of Biopharma PEG. "Our advanced PEG derivatives are designed to meet the stringent needs of modern drug development and biopharmaceutical applications. We look forward to engaging with industry leaders, sharing our latest advancements, and exploring new collaborations."

Biopharma PEG's product portfolio is designed to address the evolving challenges in drug delivery and biotechnology. During the convention, Biopharma PEG will be showcasing their latest innovations, including:

Monodispersed PEGs: Offering uniform molecular weight for precise and consistent performance.

Polydispersed PEGs: Providing a range of molecular weights for versatile application needs.

Multi-arm PEGs: Enhancing functionality with multiple reactive sites for complex drug formulations.

Attendees are encouraged to visit Booth 5102 to learn more about how Biopharma PEG's products can support and accelerate their research and development efforts. The company's technical team will be on hand to discuss specific project requirements and provide insights into their customizable solutions.

BIO 2024 is expected to attract thousands of professionals from the global biotechnology and pharmaceutical sectors, offering a prime opportunity for networking, knowledge exchange, and collaboration.

For more information about Biopharma PEG and their participation in BIO 2024, please visit or contact

About Biopharma PEG
Biopharma PEG is a leading supplier of high-quality PEG derivatives for the pharmaceutical, biotechnology, and medical device industries. With a commitment to innovation and excellence, Biopharma PEG provides a wide range of products that enhance the performance and delivery of therapeutic agents. For more information, visit .